Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00718016 · ClinicalTrials.gov registry record

Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient

A clinical trial, sponsored by Drexel University College of Medicine.

Terminated
Registry status
1
Enrollment target

NCT00718016 is a clinical trial that was terminated before completion, run by Drexel University College of Medicine. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00718016 was terminated before completion, sponsored by Drexel University College of Medicine.

TERMINATED
Registry status
1 participants
Enrollment target

Study Summary

The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2004-12
Est. Completion 2009-04

What the Registry Record Tells You About NCT00718016

The ClinicalTrials.gov registry entry for NCT00718016 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University College of Medicine, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00718016 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00718016 about?

NCT00718016 is a clinical study titled "Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient". The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complica...

What is the current status of trial NCT00718016?

This trial is currently terminated. The enrollment target is 1 participants. The study started on 2004-12. Estimated completion is 2009-04.

Who is sponsoring clinical trial NCT00718016?

This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.